4931: 新日本製薬 | 貸借残高(日証協公表)

報告日貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比新規貸付成約高前週比新規借入成約高(自己)前週比新規借入成約高(転貸)前週比
2025-01-10(金)89,633-19,600491,328-13,290155,374+26,111311,169+265,7693,909+3,90923,730-26,970
2024-12-30(月)109,233-9,800504,618-34,800129,263-62,32045,400-317,6860-17,19950,700-14,620
2024-12-27(金)119,033+42,100539,418+12,683191,583+22,499363,086+185,38617,199+17,19965,320-45,293
2024-12-20(金)76,933-58,000526,735-100169,084+1,512177,700-9,0450-3,616110,613+32,501
2024-12-13(金)134,933-2,100526,835-683167,572-38,400186,745-26,0553,616-3,38378,112+22,212
2024-12-06(金)137,033-1,900527,518+2,900205,972+19,099212,800+3,9906,999+6,09955,900+12,788
2024-11-29(金)138,933-3,429524,618+900186,873-31,212208,810-76,552900-2,49943,112+10,539
2024-11-22(金)142,362-66,093523,718-37,684218,085-38,553285,362-16,1873,399-11,97732,573-57,084
2024-11-15(金)208,455+193561,402-20,509256,638-18,234301,549+107,52515,376+10,57789,657+41,419
2024-11-08(金)208,262-2,838581,911+3,409274,872-5,562194,024+1,3964,799-26,63348,238+12,447
2024-11-01(金)211,100-11,015578,502-21,010280,434-5,605192,628+30,39531,432+8,40935,791+16,977
2024-10-25(金)222,115+7,090599,512-98,000286,039+10,224162,233+39,90323,023-10,47718,814-22,486
2024-10-18(金)215,025+25,590697,512-3,400275,815+9,500122,330-174,52633,500+14,90041,300-12,537
2024-10-11(金)189,435-52,262700,912-11,679266,315-50,306296,856-186,29218,600-102,18553,837-141,081
2024-10-04(金)241,697-99,746712,591-3,168316,621-136,130483,148-287,746120,785-186,215194,918-161,710
2024-09-27(金)341,443+134,795715,759-44,400452,751+60,669770,894+281,457307,000-67,647356,628+255,347
2024-09-20(金)206,648+12,158760,159+80,763392,082-2,904489,437+71,725374,647+80,890101,281-3,660
2024-09-13(金)194,490+91,457679,396+20,766394,986+57,758417,712+316,125293,757+200,823104,941+49,732
2024-09-06(金)103,033+37,500658,630+90,235337,228+20,287101,587+80,98792,934+81,93555,209+21,079
2024-08-30(金)65,533+128568,395-18,700316,941+43,53320,600+2,93110,999-9,79934,130-75,279